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We report experimental evidence confirming renal histopathology, proinflammatorymediators, and oxidativemetabolism induced
by cola drinking. Male Wistar rats drank ad libitum regular cola (C, 𝑛 = 12) or tap water (W, 𝑛 = 12). Measures. Body
weight, nutritional data, plasma glucose, cholesterol fractions, TG, urea, creatinine, coenzyme Q
10
, SBP, and echocardiograms
(0mo and 6mo). At 6 months euthanasia was performed. Kidneys were processed for histopathology and immunohistochemistry
(semiquantitative). Compared with W, C rats showed (I) overweight (+8%, 𝑝 < 0.05), hyperglycemia (+11%, 𝑝 < 0.05),
hypertriglyceridemia (2-fold, 𝑝 < 0.001), higher AIP (2-fold, 𝑝 < 0.01), and lower Q
10
level (−55%, 𝑝 < 0.05); (II) increased
LV diastolic diameter (+9%, 𝑝 < 0.05) and volume (systolic +24%, 𝑝 < 0.05), posterior wall thinning (−8%, 𝑝 < 0.05), and larger
cardiac output (+24%, 𝑝 < 0.05); (III) glomerulosclerosis (+21%, 𝑝 < 0.05), histopathology (+13%, 𝑝 < 0.05), higher tubular
expression of IL-6 (7-fold, 𝑝 < 0.001), and TNF𝛼 (4-fold, 𝑝 < 0.001). (IV) Correlations were found for LV dimensions with IL-6
(74%, 𝑝 < 0.001) and TNF𝛼 (52%, 𝑝 < 0.001) and fully abolished after TG and Q
10
control. Chronic cola drinking induced cardiac
remodeling associated with increase in proinflammatory cytokines and renal damage. Hypertriglyceridemia and oxidative stress
were key factors. Hypertriglyceridemic lipotoxicity in the context of defective antioxidant/anti-inflammatory protection due to low
Q
10
level might play a key role in cardiorenal disorder induced by chronic cola drinking in rats.
1. Introduction
Metabolic syndrome (MetS) is the constellation of hyper-
triglyceridemia, hyperglycemia, and/or insulin resistance,
hypertension, and visceral obesity in man. In addition to
increasing the risk for cardiovascular disease, diabetes, and
diabetic nephropathy, MetS may directly affect renal mor-
phology and/or function.
We have reported that chronic cola drinking induces
MetS, pro-oxidative metabolism, and insulin resistance in
rats and accelerates aortic atherosclerosis progression in adult
ApoE−/− mice as well [1–3].
The complex heart-kidney bidirectional dialogue involves
mediators which, via bloodstream in the midst of the
prevailing metabolic condition, reach target tissues and
deliver specific messages. We also observed that MetS
induced by chronic cola drinking might also involve renal
pathology in normal rats (unpublished observations). Sever-
ity of MetS, posing a major risk factor for cardiovascular
disease and type II diabetes, varies depending on the number
of components of the syndrome itself. Yet, the connection of
MetS with risk for renal impairment is not clear. Patients with
MetS are at high risk for chronic kidney disease [4]. Cardiore-
nal syndrome can be generally defined as a pathophysiologic
disorder of the heart and kidneys whereby acute or chronic
dysfunction in one organ may induce acute or chronic
dysfunction in the other organ [5]. By now, this condition is
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associated with significant morbidity and mortality, meeting
the attention of both cardiologists and nephrologists.
Considering that cola drinking leads to metabolic
changes which might individually affect heart and kidneys
(e.g., severe hypertriglyceridemia and insulin resistance), the
aim of this work was to evaluate whether chronic cola drink-
ing may compromise kidney integrity in relation to oxidative
metabolism and renal inflammation in rats.
2. Methods
Animal handling, maintenance, and euthanasia procedures
were performed according to international recommendations
[6]. The study was approved by the Committee of Ethics
in Animal Research of the Instituto de Investigaciones Car-
diolo´gicas and the Institutional Animal Care and Use Com-
mittee (CICUAL) of the Faculty ofMedicine of the University
of Buenos Aires. Animals were housed at the institute facili-
ties (21 + 2∘C, at 12 h light-dark cycles, 7 a.m.–7 p.m.) andwere
fed a commercial chow (16%–18% protein and 0.2 g% sodium
(Cooperacio´n, Buenos Aires, Argentina)) ad libitum.
2.1. Experimental Protocol. Twenty-four male Wistar rats
were randomly distributed in 2 groups, according to beverage
offered as the only liquid source (ad libitum): W (water) or
regular cola (C) (commercially available sucrose-sweetened
carbonated drink, Coca-Cola, Argentina). Food and drink
consumption were assessed twice a week, body weight was
determined weekly, and systolic blood pressure (SBP) was
recorded biweekly. At baseline and 6 months after the begin-
ning of the study, biochemical analyses were performed and
echocardiograms (awake rats) were recorded. After 6 months
of drinking treatment, all the animals were euthanized by
subtotal exsanguination under anesthesia (sodium thiopental
40mg/kg, i.p.) and kidneys were excised for histopathology
and immunohistochemistry.
According to company specifications Coca-Cola is a car-
bonatedwater solution containing (approximate%) 10.6 g car-
bohydrates, sodium7mg, caffeine 11.5mg, caramel, phospho-
ric acid, citric acid, vanilla extract, natural flavorings (orange,
lemon, nutmeg, cinnamon, coriander, etc.), lime juice, and
fluid extract of coca (Erythroxylum novogranatense). Cola
drink had carbon dioxide content largely removed by vigor-
ous stirring using a stirring plate and placing a magnetic bar
in a container filled with the liquid prior to being offered to
the animals at room temperature.
2.2. Biochemical Determinations. Plasma levels of glucose,
cholesterol fractions, triglycerides (TG), urea, and creatinine
were determined in blood samples collected from the tail
vein after 4-hour fasting, using commercially available kits for
enzymocolorimetry (Sigma-Aldrich, USA) [7]. Atherogenic
index of plasma (AIP) was calculated as AIP = log (TG/HDL
− total Ch).
Plasma concentration of the lipophilic antioxidant ubi-
quinone-10 (2,3 dimethoxy-5 methyl-6-decaprenyl benzo-
quinone-10, coenzyme Q
10
) was measured using reversed
phase-high performance liquid chromatography with
ultraviolet detection (RP-HPLC-UV) at absorbance wave-
length 275 nm [8].
2.3. Blood Pressure Determination. Systolic blood pressure
(SBP) was measured by tail cuff plethysmography in awake
rats gently restrained in a plastic chamber. The average of
at least 3 readings per session was recorded. A pneumatic
pulse transducer positioned on the ventral surface of the tail,
distal to the occlusion cuff, detected the return of the pulse
wave following a slow deflation of the cuff. Cuff pressure was
determined by a pneumatic pulse wave transducer, using a
programmed electrosphygmomanometer PE-300 connected
to a Physiograph MK-IIIS for pulse recording (Narco Bio-
Systems, Austin, Texas).
2.4. Echocardiography. Transthoracic echocardiograms were
obtained in awake, gently restrained rats using an ATL
3000 HDI (Bethold, WA, USA) echocardiographic system
equipped with a 10.5MHz transducer. Echocardiography
images (M-mode and 2-dimensional) were acquired in short
axis views at the level of papillary muscle. Interventricular
septal end diastolic dimension (IVSd) and left ventricular
end diastolic posterior wall dimension (LVPWd) were deter-
mined at the parasternal long axis at midchordal level. Left
ventricular diastolic dimension (LVDD) and left ventricular
end systolic posterior wall dimension (LVPWs) were mea-
sured perpendicularly to the long ventricular axis also at
midchordal level.
Typical echocardiographical parameters were calculated:
shortening fraction (Sf%) = 100× (LVPWd−LVPWs)/LVDD;
left ventricularmass (LVM) = (LVDD+RWTh+LVPWd)3 −
(LVDD)3 × 1.04; relative posterior wall thickness (RWTh) =
(LVPWd + RWTh)/LVDD; end diastolic volume (EDV) =
0.85× (LVDD)3; end systolic volume (ESV) = 0.85× (LVSD)3;
cardiac output = (EDV − ESV)∗ × heart rate; systolic volume
(SV) = EDV − ESV. Echocardiographic images and heart rate
(HR) were simultaneously recorded.
2.5. Histopathology and Quantitative Morphology. Kidneys
were immediately dissected out after euthanasia, perfused
with saline through the renal vein, weighed, and longitudi-
nally cut. After fixation in phosphate buffered 10% formalde-
hyde (pH = 7.2) for 24 h, tissue pieces were embedded in
paraffin, cut out into 4 𝜇m thick sections, and routinely
stained with hematoxylin-eosin (HE) and periodic acid-
Schiff (PAS). Tissue sections were examined under a light
microscope (Nikon Eclipse 50i, Nikon Corporation, Tokyo,
Japan) for the presence of histopathological changes. Images
were captured, converted to digital photomicrographs (Nikon
Coolpix S4), and analyzed using the Image-Pro Plus image
processing software 6.0 (Media Cybernetics, Silver Spring,
Maryland, USA). Histopathological evaluation was blinded
to the experimental group.
Kidney sections were classified according to the presence
and severity of glomerular, tubular, vascular, and intersti-
tial abnormalities using a semiquantitative scale from 0
(zero) indicating no alterations through 1+, 2+, 3+, and 4+
indicating mild, moderate, moderately severe, and severe
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abnormalities, respectively. An overall histological score for
each kidney was obtained [9].
Glomerular volume (Vg, 106 𝜇m3) was estimated based on
maximal planar area (MPA) analysis which was performed
using the point-counting method. An orthogonal grid with
300 test points, representing an area of 6.7 104 𝜇m2 at 40x
objective lens, projected onto the fields of view. The number
of points hitting the glomeruli (𝑛) was counted in ≥50
glomeruli/kidney and used to calculate MPA (𝜇m2) as = 𝑛 ×
𝑑
2, where 𝑑 is between-points distance [10].
Glomerular lesions were defined by the presence of
focal and segmental glomerular scarring and obliteration
of glomerular capillaries with increased mesangial cellular-
ity, mesangial matrix expansion, and adhesion formation
between the tuft and Bowman’s capsule. Severity of glomeru-
losclerosis was semiquantitatively determined by Raij’s
method [11].
Image analysis was performed using a Nikon Eclipse 50i
microscope (Nikon Corporation, Tokyo, Japan), incorporat-
ing a digital camera (Nikon Coolpix S4) and the Image-Pro
Plus image processing software 6.0 (MediaCybernetics, Silver
Spring, Maryland, USA).
2.6. Immunohistochemistry. The traditional avidin-biotin-
peroxidase complex technique was used and a semiquanti-
tative score allowed determination of immunohistochemical
labelling of specimens [12]. Tubular staining for thioredoxin-
1 (Trx1) (TTrx1), peroxiredoxin-2 (Prx2) (TPrx2), interleukin
(IL)-6 (TIL-6), and tumor necrosis factor-alpha (TTNF-𝛼) was
performed using respective primary polyclonal rabbit anti-
bodies. Control sections were incubated with nonimmune
normal rabbit serum. Intensity of immunochemistry positiv-
ity was determined by the integrated optical density (IOD)
method using the Image-Pro Plus image processing software
6.0 (Media Cybernetics, Silver Spring, Maryland, USA).
2.7. Statistical Analysis. Gaussian distribution was assessed
by the Kolmogorov and Smirnov method. For variables with
a Gaussian distribution (parametric), values were analyzed
by two-way ANOVA followed by post hoc tests (Bonfer-
roni multiple 𝑡-test) in order to evaluate between-groups’
differences. Pearson correlation test was used to evaluate
associations between variables (SPSS 15.0). For variables
with non-Gaussian distribution (histological scores), values
were analyzed using the Kruskal-Wallis test (non-parametric
analysis of variance) and Dunn’s multiple comparison test for
between-group comparisons. A value of𝑝 < 0.05was consid-
ered significant in all cases (GraphPad Prism 5.0, GraphPad
Software, Inc., San Diego, California, USA).
3. Results
After 6 months of cola drinking (C), rats showed large
drinking volumes (mL/kg/24 hs) (150±28 in C versus 87±12
in W, 𝑝 < 0.001) and developed overweight (+8%, 𝑝 < 0.05),
hyperglycemia (+11%, 𝑝 < 0.05), hypertriglyceridemia (2-
fold, 𝑝 < 0.001), higher AIP (2-fold, 𝑝 < 0.01), and lower
Q
10
levels (−55%, 𝑝 < 0.05) compared with their water
drinking counterparts (W) (Figure 1). Between-group differ-
ence in body weight increase over time became statistically
significant only beyond 5 months of treatment (𝑝 < 0.05 at
5 months; 𝑝 < 0.01 at 6 months, Figure 2). The decrease in
Q
10
concentration was 81% accounted for by the increase in
TG and vice versa (𝑟 = 0.90, 𝑝 < 0.01). Consumption of cola
drinks did not modify either uremia (mg/100mL) 33.3 ± 3 in
C versus 26± 4 inW or creatinine (mg/100mL: 0.53 ± 0.02 in
C versus 0.58 ± 0.04, N.S.).
Echocardiographical analysis revealed that compared
with W rats, C rats showed increased LV diastolic diameter
(+9%, 𝑝 < 0.05) and increased both LV diastolic volume
(+26%, 𝑝 < 0.01) and LV systolic volume (+24%, 𝑝 < 0.05).
Posterior wall thinning (−8%, 𝑝 < 0.05) with larger cardiac
output (+24%, 𝑝 < 0.05) and no change in heart rate (HR)
were also found in C rats compared with W rats (Figure 3).
Cola consumption had no effect on either HR or creati-
nine and did not disrupt the relationship between HR and
creatinine over time (Figure 4).
Microphotographs of renal tissue revealed focal segmen-
tal glomerulosclerosis and intense tubular immunopositivity
for IL-6 and TNF-𝛼 after 6 months of sustained cola drinking
(Figure 5).
Cola drinking treatment induced glomerulosclerosis
(+21%, 𝑝 < 0.05), higher histopathological score (+13%, 𝑝 <
0.05), and largely higher tubular expression of both IL-6 (7-
fold, 𝑝 < 0.001) and TNF-𝛼 (4-fold, 𝑝 < 0.001) (Figure 6).
Correlations were found for changes in LV dimensions
with IL-6 (74%, 𝑟 = 0.86, and 𝑝 < 0.001) and TNF-𝛼 (52%,
𝑟 = 0.72, and 𝑝 < 0.001). Controlling for either TG or Q
10
values individually reduced the strength of correlations to (%
of mutually explained variance) 22%, 𝑟 = 0.47, and 𝑝 < 0.05
for IL-6 and 14%, 𝑟 = 0.38, and 𝑝 < 0.05 for TNF-𝛼.
Moreover, controlling for both TG and Q
10
levels altogether
actually abolished any correlation previously observed for LV
dimensions with IL-6 (𝑟 = 0.20, NS) and TNF-𝛼 (𝑟 = 0.41,
NS) (Figure 7).
4. Discussion
In the present paper, the striking increase in triglycerides
following regular cola consumption can be explained by high
content of fructose and large drinking volumes in C group.
Interestingly, the decrease in Q
10
was 81% accounted for by
the increase in TG and vice versa revealing an intimate and
bidirectional metabolic connection. Hypertriglyceridemia,
increasing the demand of antioxidant factors to protect
against further lipoperoxidation, might be responsible for
exhaustion of the mitochondrial production of Q
10
level. Q
10
level has been suggested to be a useful biomarker of oxidative
stress [13]. In this regard, MetS is associated with higher
levels of circulating oxidized LDL [14]. Cola drinking induced
left ventricle hypertrophy (LVH), namely, larger diastolic
and systolic volumes with posterior wall thinning, increased
stroke volume, and cardiac output without affecting heart
rate, likely as a result of LVH and a rise in preload (EDV)
and afterload [15]. On one hand, these changes may be partly
explained by fluid overload after drinking large volumes in
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Figure 1: Body weight, biochemical profile (general metabolism), and Q
10
level before and after cola treatment. BW: body weight, TG:
triglycerides, AIP: atherogenic index in plasma, and Q
10
: coenzyme Q
10
(ubiquinone Q
10
). ∗𝑝 < 0.05 and ∗∗∗𝑝 < 0.001. Compared with
W, C rats showed overweight (+8%, 𝑝 < 0.05), hyperglycemia (+11%, 𝑝 < 0.05), hypertriglyceridemia (2-fold, 𝑝 < 0.001), higher AIP (2-fold,
𝑝 < 0.01), and lower Q
10
levels (−55%, 𝑝 < 0.05).
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Figure 2: Body weight (BW) over the time of study. ∗𝑝 < 0.05 and
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𝑝 < 0.01 versus water drinking group.
C group. Ingestion of large volumes of cola, a carbohydrate-
rich hypertonic solution having 493mOsm/L compared with
285–295mOsm/L of plasma or 3mOsm/L in hypotonic tap
water, is expected to increase blood volume and CO, through
sequestration of fluid from intracellular compartments.
Cola drinking may stimulate hypothalamic antidiuretic
hormone (ADH, vasopressin) secretion and increase blood
volume in order to keep physiological osmolarity in plasma.
The driving force responsible for the movement of fluid into
the interstitial space is regulated by circulating factors,mainly
glucose drawn from the splanchnic circulation [16]. Interest-
ingly, stimulation of ADH release would stimulate thirst in C
rats, helping to explain the large drinking volumes observed
in this group in addition to the sweet taste preference
behaviour.
On the other hand, low Q
10
levels in plasma have been
associated with cardiac hypertrophy [17]. Oppositely, Q
10
has
been reported to have a direct antihypertrophic effect on
rat cardiomyocytes in vitro and combining Q
10
with low-
dose losartan provided additive therapeutic benefit, reducing
hypertension and LVH [18].
Actually MetS is clearly linked to Q
10
deficiency [19].
In experimental and human diabetic nephropathy, advanced
glycation end products (AGEs) accumulate with malondi-
aldehyde in glomerular lesions in relation to disease severity
and in the presence of an upregulated receptor for AGE
(RAGE) in podocytes [19]. Toxic effects of AGEs result
from structural and functional alterations via cross-linking of
plasma and extracellular matrix proteins. In mesangial and
endothelial cells, AGE-RAGE interaction causes enhanced
formation of oxygen radicals with subsequent activation of
nuclear factor-kappaB and release of the proinflammatory
cytokines IL-6 and TNF-𝛼 [19].
Insofar, the effects of cola intake on glomerular structure
might be secondary to metabolic syndrome and/or they
might be related to other factors as well, such as increased
fluid overload and intravascular expansion as noted in our
previous report [1]. Present results might appear as in appar-
ent discrepancywith our earlier observations showing kidney
lesions attributable to the aging process in cola drinking
rats. However, thorough histopathology examination was not
performed in that study.
Themore we advance in the study of the effects of chronic
cola drinking, themorewemeet new pieces of themultifacto-
rial puzzle upstreammetabolic syndromemanifestations and
long-term complications. Actually,metabolic syndrome actu-
ally poses a threat to kidney structure and function in the long
run [20].
The increase in creatinine as a function of time (age of the
animals) is interpreted in terms of the functional status of the
kidney and its deterioration over time. Cola consumption did
not affect creatinine and most important did not affect heart
rate-creatinine relationship (the shape of the association
curve was unaltered) suggesting that the kidney responded
adequately to variation in heart rate over 6 months of cola
drinking. The relationship between creatinine and heart rate
has been reported [21].
On the other hand, since rats develop insulin resistance
over 6months of cola drinking as we reported [3] and present
results show an increase of inflammatory mediators in renal
tubules, the possibility that 6 months of cola drinking might
predispose to mild renal insufficiency in due time cannot be
ruled out until experimental confirmation.Mild renal insuffi-
ciency is associated with inflammation and insulin resistance
[22]. Epidemiological studies have shown an association
between the intake of cola beverages and chronic kidney
disease [23].
In a previous study, 3-month cola drinking did not affect
body weight, glomerular morphology, or oxidative status in
renal cortex [23]. In contrast, in our study, mild overweight
and glomerular histopathology were observed after 6-month
cola drinking with no change in the immunohistochemical
expression of thioredoxins, in agreement with the previous
study. Cola consumption in that study (average 140mL/day)
was similar to cola intake in the present study and both
studies evaluatedmaleWistar rats. However treatment length
was largely different and, in this experimental model as in
many others, changes over time are juxtaposed to changes due
to time (age) itself. For instance, present difference in body
weight in cola drinking rats achieved statistical significance
at 5 months, not before. Hence differences between the two
studies are interpreted mainly in terms of time-dependence
and treatment length.
The dramatic increase in proinflammatory cytokines IL-
6 and TNF-𝛼 in renal tubules induced by cola drinking
rats should result in tubular derangement and dysfunction if
sustained in time (not the aim of this study). Experimental
and clinical studies have suggested a correlation between the
progression of renal disease and dyslipidemia. Hypertriglyc-
eridemia elicits inflammatory responses in different tissues
and is known to affectmorphological integrity of kidney [24].
Dyslipidemia and lipotoxicity-induced insulin resistance,
inflammation, and oxidative stress are the key pathogeneses
of renal damage in type 2 diabetes [25]. Interestingly, we have
reported development of insulin resistance in cola drinking
rats [3]. In reasonable agreement with present evidence and
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previous reports, we suggest that MetS induced by cola
drinking affects kidney structure and increases proinflam-
matory cytokines in renal tubules in rats and that hyper-
triglyceridemia and low levels of Q
10
may play crucial roles
in determining the pathophysiology of the cardiorenal axis.
High content of advanced glycation end products (AGEs)
in caramel colorant in cola beverages further perpetuates
oxidative stress, contributing to the increase in proinflam-
matory cytokines in renal tubules and may be involved in
the progression to chronic kidney disease as one of the
complications of MetS in cola beverages consumers [26].
Five subtypes of cardiorenal alterations have been iden-
tified according to pathophysiology, time-frame, and the
nature of concomitant renal dysfunction. Cola drinking
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might be considered to induce a metabolic condition that
goes beyond the typical MetS and may progress to a type
5 cardiorenal alteration in due time (i.e., renal and cardiac
dysfunction due to a systemic metabolic condition) [27].
Chronic kidney disease is an emerging health problem
but only few patients would reach end renal stage. There
exists an increasing strong association between MetS and
chronic kidney disease though the connection between them
is unclear and there are few studies showing renal histology in
MetS [28]. Acute kidney injury has been recently reported in
a patient withmetabolic syndromewith previous normal kid-
ney function [28]. In this paper, we present evidence showing
that MetS induced by cola drinking affects renal structure
in rats and increases the level of proinflammatory cytokines
IL-6 and TNF-𝛼 in renal tubules, in the context of severe
hypertriglyceridemia and a decrease in the antioxidant/anti-
inflammatory Q
10
levels.
5. Conclusion
Chronic cola drinking induced cardiac remodeling associ-
ated with increase in proinflammatory cytokines and renal
damage. Cardiorenal association was dependent on hyper-
triglyceridemia and oxidative stress. Hypertriglyceridemic
lipotoxicity in a context of defective antioxidant and anti-
inflammatory protection due to low Q
10
level might be
involved in the cardiorenal syndrome induced by chronic cola
drinking in rats.
Based on present findings and according to the clas-
sification by Ronco et al. [5], experimental MetS induced
by chronic cola drinking, presenting cardiac hypertrophy
and renal histopathology (glomerular sclerosis) [1, 2], may
provide an interesting model to study type 5 cardiorenal syn-
drome as well.
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